Komori
Nippon Chemi-Con (6997) · InitiativeAchieved

Financing Through Stock Acquisition Rights with Adjustment Clauses for the Exercise Price

First written in FY2021-Q2. 1 of 2 entries say "Achieved", first in FY2021-Q3. Latest entry: FY2021-Q3.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021-Q22020: 120202021: 12021
Same theme, other companies

24 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 69 companies compared. The sentences above are computed from all 69.
Full recordFilings, disclosures and news, newest first
  1. FY2021-Q3AchievedAnnual report

    「During the current third-quarter accounting period, subscription rights to shares attached to bonds with subscription rights to shares and other instruments containing an exercise-price adjustment clause were exercised as follows. Cumulative number of such rights exercised as of the end of the current third-quarter accounting period: 40,000. Cumulative number of shares delivered under such instruments as of the end of the current third-quarter accounting period: 4,000,000. Cumulative funds raised under such instruments as of the end of the current third-quarter accounting period: ¥5,549 million.」

    All of the First Series Subscription Rights to Shares were exercised, 4,000,000 shares were delivered cumulatively, and funds raised totaled ¥5,549 million. The maximum allotment of 4 million shares announced in the previous quarter was exercised in full, completing the capital raising.
  2. FY2021-Q2First statedAnnual report

    「The following subscription rights to shares were issued during the current second-quarter consolidated accounting period. Class, description and number of shares underlying the subscription rights to shares: Common shares, 4,000,000. Exercise period: from 17 September 2020 to 29 September 2023.」

    Subscription rights to shares with an exercise-price adjustment clause were issued in September 2020, covering up to 4 million shares, with an initial exercise price of ¥1,691 and an exercise period from 17 September 2020 to 29 September 2023. During the second quarter, 2,511 rights were exercised, representing 251,100 shares and ¥320 million in funds raised.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nippon Chemi-Con yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Financing Through Stock Acquisition Rights with Adjustment Clauses for the Exercise Price | NIPPON CHEMI-CON CORPORATION (6997) | Komori